Pseudolaric Acid C
CAS No. 82601-41-0
Pseudolaric Acid C( —— )
Catalog No. M19150 CAS No. 82601-41-0
Pseudolaric Acid C has weak antifungal activity against Candida albicans.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 103 | In Stock |
|
| 5MG | 93 | In Stock |
|
| 10MG | 140 | In Stock |
|
| 25MG | 252 | In Stock |
|
| 50MG | 365 | In Stock |
|
| 100MG | 538 | In Stock |
|
| 200MG | 767 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePseudolaric Acid C
-
NoteResearch use only, not for human use.
-
Brief DescriptionPseudolaric Acid C has weak antifungal activity against Candida albicans.
-
DescriptionPseudolaric Acid C has weak antifungal activity against Candida albicans.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorAntifungal
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number82601-41-0
-
Formula Weight390.43
-
Molecular FormulaC21H26O7
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (256.13 mM)
-
SMILESC/C(=C\C=C\[C@@]1([C@@H]2CC[C@@]3([C@@]2(CCC(=CC3)C(=O)OC)O)C(=O)O1)C)/C(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Xingcong Li, et al. Two Auronols from Pseudolarix amabilis[J]. Journal of Natural Products, 1999, 62(5):767.
molnova catalog
related products
-
(S)-Lisofylline
(S)-Lisofylline is the inactive optical enantiomer of (R)-lisofylline which is an anti-inflammatory agent. (S)-Lisofylline is exclusively converted to pentoxifylline in human liver microsomes.
-
LY195448
LY 195448 (4-(3-(2-Hydroxy-2-phenyl)ethylamino-3-methylbutyl)benzamide) is a substance present in human blood and urine that shows antitumor activity in a mouse tumor model and blocks cells in the mid-stage.
-
Nrf2 activator-4
Nrf2 activator-4 is an Nrf2 activator that inhibits the production of reactive oxygen species in microglia for the treatment of fatty liver disease associated with metabolic dysfunction in humans.
Cart
sales@molnova.com